2020 annual financial data
Elicio Therapeutics, Inc. 2020 Operating margin
Elicio Therapeutics, Inc. 2020 operating margin with verified reported values.
Direct answer
Operating margin was -1,919.2%.
Operating income was -55,273,000 USD and net income was -80,107,000 USD.
Operating cash flow was -22,888,000 USD.
Get free Elicio Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,880,000 USD
- Operating income
- -55,273,000 USD
- Net income
- -80,107,000 USD
- Operating cash flow
- -22,888,000 USD